These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 3156917)

  • 21. Dexamethasone suppression test: use of two different dexamethasone doses.
    Hwang S; Zander J; Garvey M
    J Clin Psychiatry; 1984 Sep; 45(9):390-2. PubMed ID: 6469924
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Dexamethasone suppression in the depressed patient. Reflections apropos of an experience].
    Jonas C; Etienne T; Valat C
    Encephale; 1983; 9(2):111-22. PubMed ID: 6641613
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Dexamethasone Suppression Test in depression, in schizophrenia, and during experimental stress.
    Baumgartner A; Gräf KJ; Kürten I
    Biol Psychiatry; 1985 Jun; 20(6):675-9. PubMed ID: 3995114
    [No Abstract]   [Full Text] [Related]  

  • 24. Dexamethasone suppression test and urinary MHPG X SO4 determination in depressive disorders.
    Zhou DF; Shen YC; Shu LN; Lo HC
    Biol Psychiatry; 1987 Jul; 22(7):883-91. PubMed ID: 3607115
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mean 14.00-17.00 h plasma cortisol concentration and its relationship to the 1 mg-dexamethasone suppression response in depressives and controls.
    Holsboer F; Gerken A; Steiger A; Fass V
    Acta Psychiatr Scand; 1984 May; 69(5):383-90. PubMed ID: 6730994
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pretreatment DST and hypothalamic-pituitary-adrenocortical function in depressed patients and comparison groups. A multicenter study.
    Stokes PE; Stoll PM; Koslow SH; Maas JW; Davis JM; Swann AC; Robins E
    Arch Gen Psychiatry; 1984 Mar; 41(3):257-67. PubMed ID: 6367690
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The dexamethasone suppression test: identification of subtypes of depression.
    Schatzberg AF; Rothschild AJ; Stahl JB; Bond TC; Rosenbaum AH; Lofgren SB; MacLaughlin RA; Sullivan MA; Cole JO
    Am J Psychiatry; 1983 Jan; 140(1):88-91. PubMed ID: 6847992
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cortisol suppression index in major depressive illness.
    Fraser A
    Aust N Z J Psychiatry; 1984 Sep; 18(3):277-9. PubMed ID: 6593060
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Dexamethasone test in the diagnosis and treatment of affective psychoses].
    Evsegneev RA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1989; 89(4):98-101. PubMed ID: 2750393
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The specificity of the dexamethasone suppression test in endogenous depressive patients.
    Lu RB; Ho SL; Huang HC; Lin YT
    Neuropsychopharmacology; 1988 May; 1(2):157-62. PubMed ID: 3251496
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The dexamethasone suppression test in psychiatry.
    Joyce PR; Brinded PJ; Sellman D; Donald RA; Elder PA
    N Z Med J; 1987 Mar; 100(820):173-5. PubMed ID: 3452036
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnosis of endogenous depression. Comparison of clinical, research and neuroendocrine criteria.
    Carroll BJ; Feinberg M; Greden JF; Haskett RF; James NM; Steiner M; Tarika J
    J Affect Disord; 1980 Sep; 2(3):177-94. PubMed ID: 6210723
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dexamethasone suppression test in Brazil.
    Kerr F; Carlini EA; Sonenreich C
    Biol Psychiatry; 1990 Mar; 27(6):678-80. PubMed ID: 2322630
    [No Abstract]   [Full Text] [Related]  

  • 34. The 2-mg dexamethasone suppression test in differentiating major depression with psychosis from schizophrenia.
    Clower CG
    J Clin Psychopharmacol; 1986 Dec; 6(6):363-5. PubMed ID: 3805330
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thirty-four hour dexamethasone suppression test in depression.
    Faber R
    Psychoneuroendocrinology; 1983; 8(4):463-6. PubMed ID: 6675038
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Dexamethasone suppression test in endogenous depression and schizophrenia in male and female patients].
    Płocka M; Matkowski K; Lehmann W; Kanarkowski R; Rybakowski J
    Psychiatr Pol; 1992; 26(5):373-80. PubMed ID: 1302336
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Depression, negative and positive symptoms, and the DST in schizophrenia.
    Minas IH; Jackson HJ; Joshua SD; Burgess PM
    Schizophr Res; 1990; 3(5-6):321-7. PubMed ID: 2282337
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plasma 11-deoxycortisol and cortisol following dexamethasone in psychiatric patients.
    Joyce PR; Elder PA; Clifford JC; Brinded PJ; Donald RA
    J Psychiatr Res; 1988; 22(1):29-33. PubMed ID: 3397907
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cortisol suppression and circadian rhythm in endogenous depression: a preliminary report.
    Lee MA; Taylor MA
    Biol Psychiatry; 1983 Oct; 18(10):1127-32. PubMed ID: 6652153
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serial dexamethasone suppression test in psychiatric inpatients.
    Hwu HG; Lin HN
    Biol Psychiatry; 1990 Mar; 27(6):609-16. PubMed ID: 2322620
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.